| Aaron Stuart Cetner, MD | |
|
6330 Orchard Lake Rd, Suite 120, West Bloomfield, MI 48322-2398 | |
| (248) 694-6390 | |
| (248) 694-6391 |
| Full Name | Aaron Stuart Cetner |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 6330 Orchard Lake Rd, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982802245 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | AC093636 (Michigan) | Primary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 036.118454 (Illinois) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Center For Dermatology And Pathology Pllc | 0446330492 | 43 |
| Pinnacle Dermatology Sc | 8628353380 | 160 |
| Sami Abbasi Do Pllc | 4688869712 | 3 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
› Verified 6 days ago
| Entity Name | Ronald D Kerwin Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992754485 PECOS PAC ID: 0749280303 Enrollment ID: O20070104000186 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
› Verified 6 days ago
| Entity Name | Midwest Center For Dermatology & Pathology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003095084 PECOS PAC ID: 0446330492 Enrollment ID: O20080103000679 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
› Verified 6 days ago
| Entity Name | Sami Abbasi Do Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497079230 PECOS PAC ID: 4688869712 Enrollment ID: O20101115000342 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
› Verified 6 days ago
| Entity Name | Pinnacle Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861930984 PECOS PAC ID: 8628353380 Enrollment ID: O20181008002699 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Stuart Cetner, MD 2051 Plainfield Rd, Crest Hill, IL 60403-1865 Ph: (815) 741-4343 | Aaron Stuart Cetner, MD 6330 Orchard Lake Rd, Suite 120, West Bloomfield, MI 48322-2398 Ph: (248) 694-6390 |
News Archive
Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
› Verified 6 days ago
Tarana Marie Mohammadi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5839 W Maple Rd Ste 109, West Bloomfield, MI 48322 Phone: 248-855-7500 Fax: 248-855-5627 | |
Mrs. Suzanne Merkle, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6330 Orchard Lake Rd, #120, West Bloomfield, MI 48322 Phone: 248-855-3366 Fax: 248-855-6213 | |
Ronald David Kerwin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6330 Orchard Lake Rd, # 120, West Bloomfield, MI 48322 Phone: 248-855-3366 Fax: 248-855-6213 | |
Dr. Leonard M Cetner, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6330 Orchard Lake Rd, Suite 120, West Bloomfield, MI 48322 Phone: 248-855-3366 Fax: 248-855-6213 | |
Dr. Roxana L Chapman, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6900 Orchard Lake Rd, Ste 209, West Bloomfield, MI 48322 Phone: 248-855-7500 Fax: 248-855-5627 | |
Linda F. Stein Gold, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 6777 West Maple Road, West Bloomfield, MI 48323 Phone: 248-661-6450 Fax: 248-661-6649 | |
Dr. Kay Elizabeth Watnick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5839 W Maple Rd Ste 109, West Bloomfield, MI 48322 Phone: 248-855-7500 Fax: 248-855-5627 |